Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

The CAALA (Complex Augmentation of ALA) regimen was developed with the goal of redressing some of the weaknesses of 5-aminolevulinic acid (5-ALA) use in glioblastoma treatment as it now stands. 5-ALA is approved for use prior to glioblastoma surgery to better demarcate tumor from brain tissue. 5-ALA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kast, Richard E., Skuli, Nicolas, Sardi, Iacopo, Capanni, Felix, Hessling, Martin, Frosina, Guido, Kast, Anton P., Karpel-Massler, Georg, Halatsch, Marc-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Concept Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315943/
https://www.ncbi.nlm.nih.gov/pubmed/30469467
http://dx.doi.org/10.3390/brainsci8120203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315943/
https://www.ncbi.nlm.nih.gov/pubmed/30469467
http://dx.doi.org/10.3390/brainsci8120203

Ejemplares similares